Literature DB >> 23007808

Effect of tonsillar mononuclear cell supernatants in patients with IgA nephropathy on renal tubular epithelial cells.

Youzhou Tang1, Youming Peng, Sha Yang, Hong Liu, Gang Wu, Fuyou Liu.   

Abstract

OBJECTIVE: This study aimed to investigate the immunological relationship and the mechanism between tonsillar inflammation and immunoglobulin A nephropathy (IgAN).
SUBJECTS: Tonsillar mononuclear cells (TMCs) were prepared from 13 patients with IgAN and 13 patients with chronic tonsillitis but without renal disease. The human renal tubular epithelial cell (TEC) line, HK-2, was used to test the effects of secretions from the TMCs.
METHODS: Phytohemagglutinin (PHA) was used to induce the inflammatory responses in TMCs. The secretions from TMCs, stimulated with or without PHA, were collected and applied to HK-2 cells. The proliferation, apoptosis, and epithelial-mesenchymal transition (EMT) of HK-2 cells were evaluated. The expression of key components during apoptosis and EMT was measured.
RESULTS: The secretions from PHA-stimulated IgAN TMCs significantly inhibited proliferation, promoted apoptosis, and down-regulated Bcl-2 in HK-2 cells (P < 0.05) in time- and concentration-dependent manners. They also modulated the expression of key components during EMT, E-cadherin and α-SMA (P < 0.05).
CONCLUSIONS: The secretions from PHA-stimulated IgAN TMCs can cause the inhibition of proliferation, promotion of apoptosis, down-regulation of Bcl-2, and EMT effects in HK-2 TECs, which may reflect the in-vivo remote modulation of functions of renal TECs by tonsillar inflammation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23007808     DOI: 10.1007/s00011-012-0549-0

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  35 in total

1.  Cytokine production of RSV/PHA-stimulated tonsillar mononuclear cells: influences of age and atopy.

Authors:  S Ichinohe; I R Hussain; S L Johnston
Journal:  Eur Respir J       Date:  2003-08       Impact factor: 16.671

Review 2.  TGF-beta and epithelial-to-mesenchymal transitions.

Authors:  Jiri Zavadil; Erwin P Böttinger
Journal:  Oncogene       Date:  2005-08-29       Impact factor: 9.867

3.  Expanded primary T nodules in the palatine tonsils from patients with IgA nephropathy.

Authors:  M Kawaguchi; T Sakai; A Sakamaki; S Ishizawa; Y Baba; Y Masuda; F Koizumi
Journal:  Acta Otolaryngol Suppl       Date:  1993

Review 4.  Cellular and molecular derangements in acute tubular necrosis.

Authors:  Prasad Devarajan
Journal:  Curr Opin Pediatr       Date:  2005-04       Impact factor: 2.856

5.  Direct evidence of the production of IgA by tonsillar lymphocytes and the binding of IgA to the glomerular mesangium of IgA nephropathy patients.

Authors:  M Tokuda; J Shimizu; N Sugiyama; T Kiryu; K Matsuoka; O Sasaki; K Fukuda; O Hatase; H Monden
Journal:  Acta Otolaryngol Suppl       Date:  1996

6.  Production of interferon-gamma by tonsillar mononuclear cells in IgA nephropathy patients.

Authors:  S Fujieda; S Suzuki; H Sunaga; H Yamamoto; M Seki; H Sugimoto; H Saito
Journal:  Acta Otolaryngol       Date:  2000-08       Impact factor: 1.494

7.  Recovery following relief of unilateral ureteral obstruction in the neonatal rat.

Authors:  R L Chevalier; A Kim; B A Thornhill; J T Wolstenholme
Journal:  Kidney Int       Date:  1999-03       Impact factor: 10.612

8.  Binding of annexin V/placental anticoagulant protein I to platelets. Evidence for phosphatidylserine exposure in the procoagulant response of activated platelets.

Authors:  P Thiagarajan; J F Tait
Journal:  J Biol Chem       Date:  1990-10-15       Impact factor: 5.157

Review 9.  The role of epithelial-to-mesenchymal transition in renal fibrosis.

Authors:  Michael Zeisberg; Raghu Kalluri
Journal:  J Mol Med (Berl)       Date:  2004-01-30       Impact factor: 4.599

10.  IgA nephropathy: prognostic significance of proteinuria and histological alterations.

Authors:  Y Kobayashi; S Tateno; Y Hiki; H Shigematsu
Journal:  Nephron       Date:  1983       Impact factor: 2.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.